NCT01033383

Brief Summary

This study will investigate whether there is a particular dose of cranberry capsules that is effective in preventing the occurrence of urinary tract infections in females at least 65 years of age or older who live in a nursing home and who have a history of urinary tract infections. The Yale research team will be enrolling 80 subjects in total over several nursing home locations within Connecticut.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
80

participants targeted

Target at P75+ for phase_1

Timeline
Completed

Started Dec 2009

Geographic Reach
1 country

14 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

December 1, 2009

Completed
14 days until next milestone

First Submitted

Initial submission to the registry

December 15, 2009

Completed
1 day until next milestone

First Posted

Study publicly available on registry

December 16, 2009

Completed
10 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 1, 2010

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2010

Completed
2.7 years until next milestone

Results Posted

Study results publicly available

August 15, 2013

Completed
Last Updated

August 15, 2013

Status Verified

July 1, 2013

Enrollment Period

10 months

First QC Date

December 15, 2009

Results QC Date

March 19, 2013

Last Update Submit

July 12, 2013

Conditions

Outcome Measures

Primary Outcomes (1)

  • E.Coli Bacteriuria Plus Pyuria

    The number of urine cultures and urinalyses (obtained weekly) found with \>100,000 CFU/ml growth of E.coli and \>10 WBC.

    One month

Secondary Outcomes (2)

  • Other Bacteriuria Plus Pyuria

    one month

  • Not Growth

    one month

Study Arms (4)

3 placebo capsules

PLACEBO COMPARATOR

3 placebo capsules qd

Dietary Supplement: Placebo

1 cranberry capsule & 2 placebo capsules

EXPERIMENTAL

1 active cranberry capsule and 2 placebo capsules qd

Dietary Supplement: PlaceboDietary Supplement: Cranberry Capsule

2 cranberry capsules & 1 placebo capsule

EXPERIMENTAL

2 active cranberry capsules and 1 placebo capsules qd

Dietary Supplement: PlaceboDietary Supplement: Cranberry Capsule

3 cranberry capsules

EXPERIMENTAL

3 active cranberry capsules qd

Dietary Supplement: Cranberry Capsule

Interventions

PlaceboDIETARY_SUPPLEMENT

36 milligram (mg) placebo capsule taken before quiet hours of sleep (qhs).

1 cranberry capsule & 2 placebo capsules2 cranberry capsules & 1 placebo capsule3 placebo capsules
Cranberry CapsuleDIETARY_SUPPLEMENT

36 milligram (mg) cranberry capsule, taken before quiet hours of sleep (qhs).

Also known as: Ellura
1 cranberry capsule & 2 placebo capsules2 cranberry capsules & 1 placebo capsule3 cranberry capsules

Eligibility Criteria

Age65 Years+
Sexfemale
Healthy VolunteersYes
Age GroupsOlder Adult (65+)

You may qualify if:

  • Female nursing home residents 65 years of age or older with history of urinary tract infection within the past year.

You may not qualify if:

  • residents that are not expected to be in the nursing home for at least one month (i.e., short term rehabilitation, pending discharge, terminal \[life expectancy \< 1 month\]);
  • residents who are on chronic suppressive antibiotic or anti-infective (i.e., mandelamine) therapy for recurrent UTI;
  • residents with end stage renal disease on dialysis (they do not regularly produce urine);
  • residents unable to produce a baseline clean catch urine specimen for collection;
  • residents on warfarin therapy because of a potential interaction of warfarin and cranberry juice;
  • residents with a history of nephrolithiasis because cranberry may increase the risk of nephrolithiasis.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (14)

Northbridge Health Care Center

Bridgeport, Connecticut, 06606, United States

Location

Sheriden Woods Health Care Center

Bristol, Connecticut, 06010, United States

Location

The Carolton Chronic and Convalescent Hospital

Fairfield, Connecticut, 06824, United States

Location

Glastonbury Health Care Center

Glastonbury, Connecticut, 06033, United States

Location

Middlesex Health Care Center

Middletown, Connecticut, 06457, United States

Location

Wadsworth Glen Health Care and Rehabilitation Center

Middletown, Connecticut, 06457, United States

Location

Beacon Brook Health Care Center

Naugatuck, Connecticut, 06770, United States

Location

Laurel Ridge Health Care Center

Ridgefield, Connecticut, 06877, United States

Location

Shady Knoll Health Center

Seymour, Connecticut, 06483, United States

Location

Litchfield Woods Health Care Center

Torrington, Connecticut, 06790, United States

Location

Maefair Health Care Center

Trumbull, Connecticut, 06111, United States

Location

Masonicare Health Center

Wallingford, Connecticut, 06492, United States

Location

Abbott Terracee Health Center

Waterbury, Connecticut, 06702, United States

Location

Saint Mary Home

West Hartford, Connecticut, 06117, United States

Location

Related Publications (3)

  • Bianco L, Perrelli E, Towle V, Van Ness PH, Juthani-Mehta M. Pilot randomized controlled dosing study of cranberry capsules for reduction of bacteriuria plus pyuria in female nursing home residents. J Am Geriatr Soc. 2012 Jun;60(6):1180-1. doi: 10.1111/j.1532-5415.2012.03976.x. No abstract available.

  • Williams G, Stothart CI, Hahn D, Stephens JH, Craig JC, Hodson EM. Cranberries for preventing urinary tract infections. Cochrane Database Syst Rev. 2023 Nov 10;11(11):CD001321. doi: 10.1002/14651858.CD001321.pub7.

  • Williams G, Hahn D, Stephens JH, Craig JC, Hodson EM. Cranberries for preventing urinary tract infections. Cochrane Database Syst Rev. 2023 Apr 17;4(4):CD001321. doi: 10.1002/14651858.CD001321.pub6.

MeSH Terms

Conditions

Bacteriuria

Condition Hierarchy (Ancestors)

Urinary Tract InfectionsInfectionsUrologic DiseasesFemale Urogenital DiseasesFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesMale Urogenital Diseases

Limitations and Caveats

Of 320 urine specimens that should have been collected by nursing staff, 302 (94%) urine cultures and 294 (92%) urinalyses were obtained.

Results Point of Contact

Title
Dr. Manisha Juthani-Mehta
Organization
Yale University

Study Officials

  • Manisha Juthani-Mehta, MD

    Yale University

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
Yes

Study Design

Study Type
interventional
Phase
phase 1
Allocation
RANDOMIZED
Masking
QUADRUPLE
Who Masked
PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
PREVENTION
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

December 15, 2009

First Posted

December 16, 2009

Study Start

December 1, 2009

Primary Completion

October 1, 2010

Study Completion

December 1, 2010

Last Updated

August 15, 2013

Results First Posted

August 15, 2013

Record last verified: 2013-07

Locations